Antimicrobial activity of octenidine against multidrug-resistant Gram-negative pathogens
- 19 August 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 36 (12), 2379-2383
- https://doi.org/10.1007/s10096-017-3070-0
Abstract
Multidrug-resistant (MR) Gram-negative (GN) pathogens pose a major and growing threat for healthcare systems, as therapy of infections is often limited due to the lack of available systemic antibiotics. Well-tolerated antiseptics, such as octenidine dihydrochloride (OCT), may be a very useful tool in infection control to reduce the dissemination of MRGN. This study aimed to investigate the bactericidal activity of OCT against international epidemic clones of MRGN. A set of five different species (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii, and Pseudomonas aeruginosa) was studied to prove OCT efficacy without organic load, under “clean conditions” (0.3 g/L albumin) and under “dirty conditions” (3 g/L albumin + 3 mL/L defibrinated sheep blood), according to an official test norm (EN13727). We used five clonally unrelated isolates per species, including a susceptible wild-type strain, and four MRGN isolates, corresponding to either the 3MRGN or 4MRGN definition of multidrug resistance. A contact time of 1 min was fully effective for all isolates by using different OCT concentrations (0.01% and 0.05%), with a bacterial reduction factor of >5 log10 systematically observed. Growth kinetics were determined with two different wild-type strains (A. baumannii and K. pneumoniae), proving a time-dependent efficacy of OCT. These results highlight that OCT may be extremely useful to eradicate emerging highly resistant Gram-negative pathogens associated with nosocomial infections.Keywords
Funding Information
- University of Fribourg
- Schülke & Mayr GmbH
This publication has 16 references indexed in Scilit:
- Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment OptionsMicrobial Drug Resistance, 2016
- Efficacy of octenidine against antibiotic-resistantStaphylococcus aureusepidemic clonesJournal of Antimicrobial Chemotherapy, 2016
- Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiologyInternational Journal of Antimicrobial Agents, 2015
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwideClinical Microbiology & Infection, 2014
- Increase in Chlorhexidine Minimal Inhibitory Concentration of Acinetobacter baumannii Clinical Isolates after Implementation of Advanced Source ControlInfection Control & Hospital Epidemiology, 2014
- Antibiotic resistance—the need for global solutionsThe Lancet Infectious Diseases, 2013
- Antimicrobial activity of wound antiseptics against Extended-Spectrum Beta-Lactamase-producing bacteriaWound Medicine, 2013
- Targeted versus Universal Decolonization to Prevent ICU InfectionNew England Journal of Medicine, 2013
- Effect of Daily Chlorhexidine Bathing on Hospital-Acquired InfectionNew England Journal of Medicine, 2013
- Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniaeJournal of Hospital Infection, 2012